Terms: = Ovarian cancer AND FHIT, P49789, FRA3B, AP3Aase, ENSG00000189283, 2272 AND Diagnosis
5 results:
1. Risks of ovarian, breast, and corpus uteri cancer in women treated with assisted reproductive technology in Great Britain, 1991-2010: data linkage study including 2.2 million person years of observation.
Williams CL; Jones ME; Swerdlow AJ; Botting BJ; Davies MC; Jacobs I; Bunch KJ; Murphy MFG; Sutcliffe AG
BMJ; 2018 Jul; 362():k2644. PubMed ID: 29997145
[TBL] [Abstract] [Full Text] [Related]
2. Defining prognostic variables in recurrent endometrioid endometrial cancer: a 15-year single-institution review.
Esselen KM; Boruta DM; del Carmen M; Schorge JO; Goodman A; Growdon WB
Int J Gynecol Cancer; 2011 Aug; 21(6):1078-83. PubMed ID: 21633304
[TBL] [Abstract] [Full Text] [Related]
3. [Promoter hypermethylation gene patterns in gynecological tumors].
Leal Rojas P; Anabalón Rodríguez L; García Muñoz P; Tapia Escalona O; Guzmán González P; Araya Orostica JC; Villaseca Hernández M; Roa Strauch JC
Med Clin (Barc); 2009 Mar; 132(10):371-6. PubMed ID: 19268989
[TBL] [Abstract] [Full Text] [Related]
4. Cytologic features of granulosa cell tumors in fluids and fine needle aspiration specimens.
Lal A; Bourtsos EP; Nayar R; DeFrias DV
Acta Cytol; 2004; 48(3):315-20. PubMed ID: 15192945
[TBL] [Abstract] [Full Text] [Related]
5. Comparative analysis of loss of heterozygosity of specific chromosome 3, 13, 17, and X loci and TP53 mutations in human epithelial ovarian cancer.
Manderson EN; Presneau N; Provencher D; Mes-Masson AM; Tonin PN
Mol Carcinog; 2002 Jun; 34(2):78-90. PubMed ID: 12112314
[TBL] [Abstract] [Full Text] [Related]
